Opdivo 10 mg

OPDIVO 10 MG is an intravenous solution containing nivolumab, used for various therapeutic purposes. This medication is manufactured by Bristol-Myers Squibb Canada and is available in a 4 mL pack size.

OPDIVO 10 MG is primarily used in the treatment of certain types of cancer. Nivolumab, the active ingredient, works by helping the immune system to fight cancer cells. This medication may be prescribed for conditions where the immune system needs support to target and destroy cancer cells effectively.

Common effects of OPDIVO 10 MG may include fatigue, nausea, and skin reactions. Some individuals might experience changes in appetite or weight. It is important to discuss any persistent or severe effects with a healthcare provider.

OPDIVO 10 MG should be handled with care and administered under medical supervision. It is crucial to inform healthcare providers about any existing medical conditions or allergies. Proper storage and handling instructions should be followed to maintain the medication's efficacy.

OPDIVO 10 MG may interact with other medications, including those that affect the immune system. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and certain supplements may also affect the medication's performance.